C12N2760/12211 - CPC Classification Index

ClassID:

110703 ⎘

C12N2760/12211 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Bunyaviridae Phlebovirus, e.g. Rift Valley fever virus

Sub-classes:

C12N2760/12221 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 14
C12N2760/12222 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 13
C12N2760/12223 » Virus like particles [VLP] 5
C12N2760/12231 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
C12N2760/12232 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 1
C12N2760/12233 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 3
C12N2760/12234 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 26
C12N2760/12241 » Use of virus, viral particle or viral elements as a vector 0
C12N2760/12251 » Methods of production or purification of viral material 2
C12N2760/12261 » Methods of inactivation or attenuation 1
C12N2760/12271 » Demonstrated in vivo effect 3
C12N2760/12288 » For redistribution 0

Recent Application in this class:

20180244757

2018-08-30

Monoclonal antibodies specific for heartland virus and methods of their use

20160331827

2016-11-17

Recombinant rift valley fever (RVF) viruses and methods of use

20140275037

2014-09-18

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

20140134207

2014-05-15

Recombinant rift valley fever (RVF) viruses and methods

20110123567

2011-05-26

Recombinant Rift Valley fever (RVF) viruses and methods of use

20110008384

2011-01-13

Antiviral activity from medicinal mushrooms

20100183638

2010-07-22

RESTRICTIVE AGONIST OF TOLL-LIKE RECEPTOR 3 (TLR3)

20090203675

2009-08-13

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses

20060171958

2006-08-03

Antiviral activity from medicinal mushrooms

#10

20050238655

2005-10-27

Antiviral activity from medicinal mushrooms